ASCO research highlights: First KRAS inhibitor and CAR T cell therapy for CLL

June 28, 2019 | City of Hope

At ASCO, City of Hope presented on a number of topics, but some of the most noteworthy involved the first KRAS inhibitor to show anti-tumor activity and the use of CAR T cell therapy in chronic lymphocytic leukemia.

Continue Reading

Immunotherapy combo could tackle advanced cancers

June 18, 2019 | Zen Vuong

City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly impossible-to-treat cancer into a disease that can be corralled into remission.

Inspired by sci-fi, radiologist forges new frontiers in cancer diagnostics

June 4, 2019 | Maxine Nunes

Ammar Chaudhry, M.D., a radiologist with degrees in biology and physics and founder and director of City of Hope’s new Precision Imaging Lab, is currently working with some paradigm-shifting concepts that promise to transform the diagnosis and treatment of cancer patients.

Colorectal tumor biomarker may predict immunotherapy effectiveness

May 2, 2019 | Zen Vuong

The takeaway of foundational research by a City of Hope physician-scientist and his colleagues is that patients with metastatic colorectal cancer and a high tumor mutation score should consider immunotherapy as initial treatment.

Combined immunotherapy could tackle advanced cancers

April 15, 2019 | Zen Vuong

City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly impossible-to-treat cancer into a disease that can be corralled into remission.

Def Leppard guitarist defies cancer diagnosis

March 29, 2019 | Samantha Bonar

Def Leppard guitarist Vivian Campbell was diagnosed with Hodgkin's lymphoma in 2013. After chemotherapy and a stem cell transplant failed, immunotherapy has kept his cancer at bay for the last four years.